Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic ch...
DAYANG BIOTECH released its performance for the first three quarters, with a net profit attributable to the parent company of 80.366 million yuan, an increase of 56.12%
DAYANG BIOTECH issued a preliminary increase, expecting the net profit attributable to the parent company for the first three quarters to be between 74 million yuan and 90 million yuan, a year-on-year increase of 44.35% to 75.56%
The A-share chemical and chemical engineering sector fluctuated and strengthened, JJKJ hit the daily limit, DAYANG BIOTECH rose over 5%, JSAC, LIER CHEMICAL, and Yangnong Chemical followed suit
DAYANG BIOTECH: In the first half of the year, the net profit attributable to the parent company was 50.5056 million yuan, a year-on-year increase of 60.66%
DAYANG BIOTECH: The Zhejiang Regulatory Bureau has taken corrective measures against the company's shareholder Yang Xingli and his concerted actors
The research enthusiasm for star companies is high, and leading enterprises frequently release positive signals